Stempeutics Research Pvt Ltd   Report issue

For profit Phase 2
Founded: Bengaluru India (2006)
Status: Left NME R&D (2022)

Organization Overview

First Clinical Trial
2009
NCT00883727
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fibrosis (Phase 2)

Infarction (Phase 2)

Ischemia (Phase 2)

Liver Cirrhosis (Phase 2)

Liver Cirrhosis, Alcoholic (Phase 2)

Myocardial Infarction (Phase 2)

Osteoarthritis (Phase 2)

Osteoarthritis, Knee (Phase 2)

Stroke (Phase 2)

Thromboangiitis Obliterans (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 8
  • # of Trial APIs: 5